The Act defines its technical and legal terms with care. "Gene technology" is any technique for modification of genes or other genetic material, excluding sexual reproduction and homologous recombination and any other techniques specified in regulation (s 10). "Genetically modified organism" (GMO) is defined broadly to include organisms modified by gene technology or that inherit traits from such organisms, subject to regulatory exclusions and an express carve‑out for human beings covered only by somatic cell gene therapy (s 10). The Act also allows regulations to declare other things to be GMOs or not to be GMOs (s 10).
"Deal with", in relation to a GMO, is a purposely wide concept and includes experiments, making, breeding, propagation, use in manufacture, growing, importing, transporting and disposal, and possession, supply or use in the course of those activities (s 10). The Act separately identifies an "intentional release of a GMO into the environment" to mean an intentional release into the open environment, whether or not there are measures limiting dissemination or persistence (s 11). That threshold drives which procedural path applies: Division 3 tracks dealings not involving intentional release while Division 4 applies to applications involving intentional release (ss 46-50).
Three authorisation pathways are central. First, the core GMO licence permits specified dealings and can be applied for by a person to authorise dealings by specified persons or classes of persons (s 40). Licence conditions are modular and may cover containment levels, monitoring, waste disposal, geographic limits, insurance and more (ss 61-66, s 62). Second, the emergency dealing determination regime authorises specified dealings by Ministerial order in response to an emergency and may impose conditions; it operates only where a corresponding Commonwealth emergency determination exists or is proposed (ss 72B-72E). Third, the Act allows regulation to declare certain dealings as notifiable low risk dealings, which can be regulated by requirements such as notification, supervision by Institutional Biosafety Committees or containment levels (ss 74-75). There is also an administrative path for including particular dealings on the public GMO Register so they are available to be undertaken by any person subject to conditions (ss 76-80).
Certification of facilities to containment levels and accreditation of organisations are mechanisms to operationalise compliance outside the licensing decision. The Regulator may certify facilities to containment levels against guidelines (ss 83-90) and may accredit organisations that have Institutional Biosafety Committees and relevant arrangements (ss 91-98). Licence conditions may require certified facilities or accredited supervision (s 62(2)(e), (m)).
Risk assessment and consultation are procedural requirements. The Regulator must prepare a risk assessment and risk management plan before issuing licences (ss 47, 50). For intentional release applications the Regulator must consult States, the Gene Technology Technical Advisory Committee, prescribed Commonwealth agencies, Environment Australia and relevant local councils, unless the application falls within the limited and controlled release threshold in s 50A (s 50(3) and s 50A). The Regulator must publish notice about risk assessments and invite submissions, with minimum submission periods,30 days normally and 50 days if the Regulator is satisfied a significant risk may be posed (s 52).
Transparency and confidentiality compete in the regime. The Record must include licence details, emergency determinations, and notified low risk dealings except for confidential commercial information (s 138). Applicants may apply for a confidential commercial information declaration and the Regulator must make or refuse that declaration according to specified criteria, with a particular rule that information about field trial locations will generally not be declared confidential unless significant damage would result from disclosure (ss 184-186, s 185(2A), s 185(3A)).
Enforcement and investigatory concepts are integrated. Inspectors are appointed by the Regulator and carry identity cards (ss 150-151). Monitoring powers permit entry with consent, under warrant, or in specified circumstances (ss 152-153). Offence‑related and emergency powers allow search, seizure and immediate steps to prevent imminent risk (ss 154-158). The Regulator can give directions to licence holders and persons covered by licences and arrange for remedial steps to be taken at the addressee’s cost (s 146).
The Act expressly seeks national consistency with the Commonwealth framework and allows certain State actions to be subordinated to or aligned with Commonwealth measures and Ministerial Council instruments (ss 5, 5A, 16, 21-24). The Regulator is given operational independence in individual licensing decisions (s 30), but the Regulator must have regard to policy guidelines and must not issue licences inconsistent with policy principles issued by the Ministerial Council (s 56-57, s 21).
These concepts structure who decides (Regulator, Minister, Ministerial Council), what permission routes exist (licence, emergency determination, notifiable low risk dealing, GMO Register, exempt dealings), how risk and transparency are managed (risk assessments, Record, confidentiality), and how compliance is enforced (inspectors, directions, fines, criminal penalties, forfeiture, warrants).